Warsaw-based Jutro Medical, an AI-first primary care operator combining online and in-person care, has raised €24 million in new funding led by Warsaw Equity Group, with participation from Vinci, naturalX Health Ventures, Fluent Ventures, Aternus, KAYA VC, and Inovo VC. The round also includes a debt component from mBank and Orbit Capital. The raise extends the company’s previously announced Series A, bringing the total to €36 million.
Founded in 2020, Jutro Medical has grown from a single clinic focused on technology-enabled care into an integrated primary care operator with its own electronic health record (EHR), standardised clinic operations, and AI-based tools.
In its first four years, Jutro Medical prioritised building a proprietary EHR and the underlying software and data infrastructure used across its clinics. The company says this foundation has enabled it to add an AI layer more efficiently, allowing AI agents to support administrative tasks such as intake and drafting visit documentation. Clinicians begin appointments with relevant context prepared, review and adjust information as needed, and retain responsibility for all clinical decisions. Use of AI is optional, and patients can choose a traditional appointment.
The company’s approach is positioned against broader pressures in primary care, where workforce shortages, rising administrative workloads, and uneven access continue to limit capacity. Primary care spending in Europe exceeds €200 billion annually, including around €9 billion in Poland, yet many clinics still rely on manual or paper-based processes that can slow access to care.
Jutro Medical follows an acquisition-led strategy, bringing acquired clinics onto a shared operating and technology platform that includes a common EHR, workflows, and AI tools. The company says it added nine clinics to its network this year and is targeting around 20 acquisitions annually, with the aim of supporting more consistent service delivery and faster integration.
By running our own clinics on our own software, we’ve learned firsthand which tasks can be handled by AI. Instead of hiring more staff, we now build AI agents that do the same work – freeing clinicians to practice medicine, not paperwork. These agents already manage thousands of patients interactions every month,
says Adam Janczewski, founder and CEO of Jutro Medical.
The new capital will be used to support further clinic acquisitions in Poland and to expand the model into other European markets. Jutro Medical also plans to continue developing AI agents to automate additional administrative and operational tasks, while clinicians focus on diagnosis and treatment.
Over the longer term, the company aims to build a pan-European primary care operator by consolidating a fragmented market of small practices.
Would you like to write the first comment?
Login to post comments